2-(2-((2-(2,6-Dimethylphenoxy)ethyl)thio)-1-benzimidazolyl)acetic acid
CAS : 312928-72-6
Ref. 3D-MMA92872
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
2-((2-((2-(2,6-dimethylphenoxy)ethyl)thio)-1-benzimidazolyl)acetic acid (DMPXAA) is a small molecule that binds to the GABA receptor. It acts as an activator of the receptor and has been shown to have strong analgesic effects in animals. DMPXAA also inhibits the activity of ion channels and ligand binding to receptors. It has been used as a research tool for studying neuronal excitability, protein interactions, and receptor function.
DMPXAA has no known side effects and is not toxic when administered at doses up to 2000 mg/kg in mice.